Evidence map›Paper›PMID 35872099›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2022

Clinical-epidemiologic variation in patients treated in the first and second wave of COVID-19 in Lambayeque, Peru: A cluster analysis.

Mario J Valladares-Garrido, Virgilio E Failoc-Rojas, Percy Soto-Becerra, Sandra Zeña-Ñañez, J Smith Torres-Roman, Jorge L Fernández-Mogollón, Irina G Colchado-Palacios, Carlos E Apolaya-Segura, Jhoni A Dávila-Gonzales, Laura R Arce-Villalobos and 5 more

Abstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Post-Traumatic Stress Associated with Telework-Related Job Limitation in Latin America.International journal of environmental research and public health · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Mario J Valladares-GarridoInstituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Peru; South American Center for Education and Research in Public Health, Universidad Norbert Wiener, Lima, Peru.
Virgilio E Failoc-RojasInstituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Peru; Universidad San Ignacio de Loyola, Lima, Peru. Electronic address: virgiliofr@gmail.com.
Percy Soto-BecerraInstituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Peru; Universidad Continental, Huancayo, Peru.
Sandra Zeña-ÑañezInstituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Peru; Universidad Continental, Huancayo, Peru.
J Smith Torres-RomanFacultad de Ciencias de la Salud, Universidad Científica del Sur, Lima, Peru.
Jorge L Fernández-MogollónHospital Nacional Almanzor Aguinaga Asenjo, EsSalud, Chiclayo, Peru.
Irina G Colchado-PalaciosHospital Nacional Almanzor Aguinaga Asenjo, EsSalud, Chiclayo, Peru.
Carlos E Apolaya-SeguraHospital Nacional Almanzor Aguinaga Asenjo, EsSalud, Chiclayo, Peru.
Jhoni A Dávila-GonzalesHospital Nacional Almanzor Aguinaga Asenjo, EsSalud, Chiclayo, Peru.
Laura R Arce-VillalobosHospital Nacional Almanzor Aguinaga Asenjo, EsSalud, Chiclayo, Peru.
Roxana Del Pilar Neciosup-PuicanHospital Nacional Almanzor Aguinaga Asenjo, EsSalud, Chiclayo, Peru.
Alexander G Calvay-RequejoHospital Nacional Almanzor Aguinaga Asenjo, EsSalud, Chiclayo, Peru.
Jorge L MaguiñaInstituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Peru; Facultad de Ciencias de la Salud, Universidad Científica del Sur, Lima, Peru.
Moisés Apolaya-SeguraInstituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Peru; Facultad de Medicina, Universidad Cesar Vallejo, Chiclayo, Peru.
Cristian Díaz-VélezInstituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Peru; Facultad de Medicina, Universidad Privada Antenor Orrego, Trujillo, Peru.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo identify differences in the clinical and epidemiologic characteristics of patients during the first and second waves of the COVID-19 pandemic at the EsSalud Lambayeque health care network, Peru.

methodsAn analytical cross-sectional study of 53,912 patients enrolled during the first and second waves of COVID-19 was conducted. Cluster analysis based on clustering large applications (CLARA) was applied to clinical-epidemiologic data presented at the time of care. The two pandemic waves were compared using clinical-epidemiologic data from epidemiologic surveillance.

resultsCluster analysis identified four COVID-19 groups with a characteristic pattern. Cluster 1 included the largest number of participants in both waves, and the participants were predominantly female. Cluster 2 included patients with gastrointestinal, respiratory, and systemic symptoms. Cluster 3 was the "severe" cluster, characterized by older adults and patients with dyspnea or comorbidities (cardiovascular, diabetes, obesity). Cluster 4 included asymptomatic, pregnant, and less severe patients. We found differences in all clinical-epidemiologic characteristics according to the cluster to which they belonged.

conclusionUsing cluster analysis, we identified characteristic patterns in each group. Respiratory, gastrointestinal, dyspnea, anosmia, and ageusia symptoms were higher in the second COVID-19 wave than the first COVID-19 wave.

Indexed as

COVID-19AgedCluster AnalysisCross-Sectional StudiesDyspneaFemaleHumansMalePandemicsPeruPregnancyCluster analysisCoronavirus infectionCOVID-19Pandemic wavePeruSymptoms

Identifiers

PMID35872099
PMCPMC9303067

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.